Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1426-1434

  Biosse Duplan, Martin ^a   Baroukh, Brigitte ^a   Dy, Michel ^b   De Vernejoul, Marie Christine ^c   Saffar, Jean Louis ^a  

^a and Plateforme d'Imagerie du Vivant   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; FAMOTIDINE; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEPYRAMINE; OSTEOPROTEGERIN; ANTIHISTAMINIC AGENT; HISTAMINE RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; DENTIN; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MANDIBLE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; SPLEEN CELL; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION; HUMAN; METABOLISM; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CHEMOTAXIS, LEUKOCYTE; GENE EXPRESSION; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MONOCYTES; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RATS; RECEPTORS, HISTAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 65349125342     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080871     Document Type: Article

References (39)

1. Teitelbaum SL: Bone resorption by osteoclasts. Science 2000, 289:1504-1508
2. Bianco P, Riminucci M, Gronthos S, Robey PG: Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192
3. Khosla S: Minireview: the OPG/RANKL/RANK system. Endocrinology 2001, 142:5050-5055
4. Martin TJ, Sims NA: Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005, 11:76-81
5. Kacena MA, Gundberg CM, Horowitz MC: A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone 2006, 39:978-984
6. Dy M, Schneider E: Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 2004, 15:393-410
7. Fouilloux I, Duplan MB, Baroukh B, Cherruau M, Saffar JL, Lesclous P: Mast cell activation and degranulation occur early during induction of periosteal bone resorption. Bone 2006, 38:59-66
8. de Gennes C, Kuntz D, de Vernejoul MC: Bone mastocytosis. A report of nine cases with a bone histomorphometric study. Clin Orthop Relat Res 1992, 279:281-291
9. Brumsen C, Papapoulos SE, Lentjes EG, Kluin PM, Hamdy NA: A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 2002, 31:556-561
10. Corbel S, Schneider E, Lemoine FM, Dy M: Murine hematopoietic progenitors are capable of both histamine synthesis and uptake. Blood 1995, 86:531-539
11. Lesclous P, Guez D, Saffar JL: Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H(2) receptor antagonist cimetidine. Bone 2002, 30:131-136
12. Yamaura K, Yonekawa T, Nakamura T, Yano S, Ueno K: The hista- mine H2-receptor antagonist, cimetidine, inhibits the articular os- teopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine. J Pharmacol Sci 2003, 92:43-49
13. Fitzpatrick LA, Buzas E, Gagne TJ, Nagy A, Horvath C, Ferencz V, Mester A, Kari B, Ruan M, Falus A, Barsony J: Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss. Proc Natl Acad Sci USA 2003, 100:6027-6032
14. Deyama Y, Kikuiri T, Ohnishi G, Feng YG, Takeyama S, Hatta M, Yoshimura Y, Suzuki K: Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-kappaB li- gand by osteoblasts. Biochem Biophys Res Commun 2002, 298:240-246
15. Ikawa Y, Yonekawa T, Ohkuni Y, Kuribayashi M, Fukino K, Ueno K: A comparative study of histamine activities on differentiation of osteo- blasts and osteoclasts. J Toxicol Sci 2007, 32:555-564
16. Tran Van PT, Vignery A, Baron R: Cellular kinetics of the bone remodeling sequence in the rat. Anat Rec 1982, 202:445-451
17. Baron R, Neff L, Tran Van P, Nefussi JR, Vignery A: Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 1986, 122: 363-378
18. Baroukh B, Cherruau M, Dobigny C, Guez D, Saffar JL: Osteoclasts differentiate from resident precursors in an in vivo model of synchronized resorption: a temporal and spatial study in rats. Bone 2000, 27:627-634
19. Cherruau M, Morvan FO, Schirar A, Saffar JL: Chemical sympathec- tomy-induced changes in TH-, VIP-, and CGRP-immunoreactive fibers in the rat mandible periosteum: influence on bone resorption. J Cell Physiol 2003, 194:341-348
20. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, Hirasawa N, Sakurai E, Buzas E, Kovacs P, Csaba G, Kittel A, Okada M, Hara M, Mar L, Numayama-Tsuruta K, Ishigaki-Suzuki S, Ohuchi K, Ichikawa A, Falus A, Watanabe T, Nagy A: Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001, 502:53-56
21. Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y: Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 2005, 202:589-595
22. Fitzsimons CP, Monczor F, Fernandez N, Shayo C, Davio C: Mepyra- mine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein. J Biol Chem 2004, 279:34431-34439
23. Aichberger KJ, Mayerhofer M, Vales A, Krauth MT, Gleixner KV, Bilban M, Esterbauer H, Sonneck K, Florian S, Derdak S, Pickl WF, Agis H, Falus A, Sillaber C, Valent P: The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells. Blood 2006, 108: 3538-3547
24. Lebel B: A high-sampling-rate automated continuous-flow fluoromet- ric technique for the analysis of nanogram levels of histamine in biological samples. Anal Biochem 1983, 133:16-29
25. Merciris D, Marty C, Collet C, de Vernejoul MC, Geoffroy V: Overex- pression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo. Am J Pathol 2007, 170:1676-1685
26. Saffar JL, Klapisz-Wolikow M: Changes in mast cell number during the activation phase of an induced synchronized remodeling sequence in the rat. Bone 1990, 11:369-372
27. Tang L, Jennings TA, Eaton JW: Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci USA 1998, 95:8841-8846
28. Laszlo V, Rothe G, Hegyesi H, Szeberenyi JB, Orso E, Schmitz G, Falus A: Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesized histamine in monocyte/macrophage differentiation. Inflamm Res 2001, 50:428-434
29. Sasaguri Y, Tanimoto A: Role of macrophage-derived histamine in atherosclerosis-chronic participation in the inflammatory response. J Atheroscler Thromb 2004, 11:122-130
30. Liu YZ, Dvornyk V, Lu Y, Shen H, Lappe JM, Recker RR, Deng HW: A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem 2005, 280:29011-29016
31. Chiappetta N, Gruber B: The role of mast cells in osteoporosis. Semin Arthritis Rheum 2006, 36:32-36
32. Wang KY, Arima N, Higuchi S, Shimajiri S, Tanimoto A, Murata Y, Hamada T, Sasaguri Y: Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. FEBS Lett 2000, 473:345-348
33. Soga F, Katoh N, Kishimoto S: Histamine prevents apoptosis in human monocytes. Clin Exp Allergy 2007, 37:323-330
34. Lesclous P, Guez D, Baroukh B, Vignery A, Saffar JL: Histamine participates in the early phase of trabecular bone loss in ovariecto- mized rats. Bone 2004, 34:91-99
35. Hasturk H, Kantarci A, Ebrahimi N, Andry C, Holick M, Jones VL, Van Dyke TE: Topical H2 antagonist prevents periodontitis in a rabbit model. Infect Immun 2006, 74:2402-2414
36. Ferencz V, Meszaros S, Csupor E, Toth E, Bors K, Falus A, Horvath C: Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy. Osteoporos Int 2006, 17:484-491
37. Graves L, 3rd, Stechschulte DJ, Morris DC, Lukert BP: Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes. J Bone Miner Res 1990, 5:1113-1119
38. Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL: The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is devel- opmentally regulated. Endocrinology 2000, 141:4768-4776
39. Pochampally RR, Ylostalo J, Penfornis P, Matz RR, Smith JR, Prockop DJ: Histamine receptor H1 and dermatopontin: new downstream targets of the vitamin D receptor. J Bone Miner Res 2007, 22: 1338-1349